These functional benefits are mediated through convergent intracellular signaling cascades: BDNF activates tropomyosin receptor kinase B (TrkB)-dependent Phosphatidylinositol 3-kinase/Protein kinase B (PI3K/Akt) and Mitogen-activated protein kinase/Extracellular signal-regulated kinase (MAPK/ERK) pathways to enhance survival and synaptic plasticity, reducing apoptosis and preserving retinal structure in hyperglycemic conditions (34, 162, 183)
In the UK, weight management is approached through a structured, evidence-based framework aligned with NICE guideline CG189 (Obesity: identification, assessment and management) and NICE guideline PH53 (Weight management: lifestyle services for overweight or obese adults)
Studies suggest semaglutide may reduce CRP and other inflammatory markers, though these effects may be largely attributable to significant weight reduction rather than direct anti-inflammatory action
Compounding is a legitimate, regulated pharmaceutical practice that has existed for a long time
Stop taking your GLP-1 forever. This move seems like a doctor protecting the patient, but I worry it is something else
2013, 304, E677E685